Inclusion Criteria : 
  -  Informed Consent as documented by signature
  -  Diagnosis of non - invasive ( stage 0 ) or invasive ( stage 1 , 2 and 3 A ) breast adenocarcinoma
  -  Treatment with primary breast - sparing surgery ( lumpectomy ) and / or neoadjuvant ( pre operative ) or adjuvant ( post operative ) chemotherapy or hormonal therapy
  -  Scheduled for post operative radiotherapy at Ziekenhuis Oost - Limburg , Genk : 
  -  Hypofractionated radiotherapy regimen ( i. e.  16 daily fractions of 2.66 Gray to the whole breast followed by a boost of 5 fractions of 2.66 Gray to the tumor bed , 5 x / week )     
Exclusion Criteria : 
  -  Scheduled for post operative radiotherapy at Jessa Hospital , Hasselt , Belgium
  -  Previous irradiation to the same breast
  -  Metastatic disease
  -  Concurrent chemotherapy
  -  Required use of bolus material to deliver radiotherapy ( i. e material placed on the to - be - irradiated zone to modulate the delivered dose in order to ensure an optimal distribution of the radiation dose; mostly used for treatment of superficial tumors ) 
  -  Known or suspected non - compliance , drug or alcohol abuse
  -  Inability to follow the procedures of the study , e. g.  due to language problems , psyschological disorders , dementia , etc.  of the participant
  -  Seizure
  -  Disorders triggered by lighttake anticoagulants
  -  Hemorrhagic diatheses
  -  Pregnancy
  -  Suspected of carrying serious infectious disease
  -  HIV positive history
